Is it truly pulmonary arterial hypertension?
Registration for this session is additional to the congress registration fee and is €122 on site, €110 standard.
Aims : The diagnosis of pulmonary arterial hypertension is becoming more complex because patients present with more comorbidities. These comorbidities range from metabolic syndrome to coronary artery disease and/or mild lung parenchymal diseases. The aim of this session is to present three different cases of patients who were referred for treatment of PAH that may have developed via different pathophysiological mechanisms.
Target audience :
Clinician, Emergency medicine doctor, Fellow, General practitioner, Intensivist/critical care physician, Junior member, Nurse, Patient, Pharmaceutical industry representative, Pulmonologist, Radiologist, Resident, Researcher, Respiratory physician, Respiratory therapist, Scientist, Student, Trainee